Aimmune Therapeutics, Inc.
Q2 2020 13F Holders
Symbol
AIMT
CUSIP
00900T107
Type
Equity
Class
COM
Num filings
180
Total reported value, excl. options
$824 M
Compare 2020 Q2 to
2021 Q3
2021 Q2
2021 Q1
2020 Q4
2020 Q3
2020 Q1
2019 Q4
2019 Q3
2019 Q2
2019 Q1
2018 Q4
2018 Q3
2018 Q2
2018 Q1
2017 Q4
2017 Q3
2017 Q2
2017 Q1
2016 Q4
2016 Q3
2016 Q2
2016 Q1
2015 Q4
2015 Q3
Manager
Report Date
Value ($000)
Shares
Option Type